1. Effect Modification between Genes and Environment and Parkinson's Disease Risk
- Author
-
Maria Teresa Periñán, Kajsa Brolin, Sara Bandres‐Ciga, Cornelis Blauwendraat, Christine Klein, Ziv Gan‐Or, Andrew Singleton, Pilar Gomez‐Garre, Maria Swanberg, Pablo Mir, Alastair Noyce, Aligning Science Against Parkinson's ASAP, Michael J. Fox Foundation for Parkinson's Research, National Institute on Aging (US), National Institutes of Health (US), and Barts Charity
- Subjects
Neurology ,Humans ,Parkinson Disease ,Penetrance ,Neurology (clinical) - Abstract
Parkinson's disease (PD) is a complex neurodegenerative condition in which genetic and environmental factors interact to contribute to its etiology. Remarkable progress has been made in deciphering disease etiology through genetic approaches, but there is limited data about how environmental and genetic factors interact to modify penetrance, risk, and disease severity. Here, we provide insights into environmental modifiers of PD, discussing precedents from other neurological and non-neurological conditions. Based on these examples, we outline genetic and environmental factors contributing to PD and review potential environmental modifiers of penetrance and clinical variability in monogenic and idiopathic PD. We also highlight the potential challenges and propose how future studies might tackle these important questions. ANN NEUROL 2022;92:715-724., This work was supported in part by the Global Parkinson's Genetics Program (GP2). GP2 is funded by the Aligning Science Against Parkinson's (ASAP) initiative and implemented by The Michael J. Fox Foundation for Parkinson's Research (https://gp2.org). For a complete list of GP2 members see https://gp2.org. This research was supported in part by the Intramural Research Program of the National Institutes of Health (National Institute on Aging, Z01-AG000949-02). The Preventive Neurology Unit is funded by the Barts Charity.
- Published
- 2022